Trust, The fragile foundation of contemporary biomedical research.

It is widely assumed that informing prospective subjects about the risks and possible benefits of research not only protects their rights as autonomous decisionmakers, but also empowers them to protect their own interests. Yet interviews with patient-subjects conducted under the auspices of the Advisory Committee on Human Radiation Experiments suggest this is not always the case. Patient-subjects often trust their physician to guide them through decisions on research participation. Clinicians, investigators, and IRBs must assure that such trust is not misplaced.

[1]  J. H. Jones The Tuskegee legacy. AIDS and the black community. , 1992, The Hastings Center report.

[2]  I. Tannock,et al.  Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Rodenhuis,et al.  Patient motivation and informed consent in a phase I study of an anticancer agent. , 1984, European journal of cancer & clinical oncology.

[4]  M. Ratain,et al.  Perceptions of cancer patients and their physicians involved in phase I trials. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Holland,et al.  Informed consent for investigational chemotherapy: patients' and physicians' perceptions. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  E. Lusk,et al.  Attitudes toward clinical trials among patients and the public. , 1982, JAMA.

[7]  S. Bok Shading the Truth in Seeking Informed Consent for Research Purposes , 1995, Kennedy Institute of Ethics journal.

[8]  A. Baier Trust and Antitrust , 1986, Ethics.